GHRS: GH Research PLC Stock

by  •  • Comments Off on GHRS: GH Research PLC Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 582.19
Enterprise Value ($M) 504.71
Book Value ($M) 218.97
Book Value / Share 4.03
Price / Book 2.78
NCAV ($M) 156.76
NCAV / Share 3.01
Price / NCAV 3.71

Profitability (mra)
Return on Invested Capital (ROIC) -0.15
Return on Assets (ROA) -0.13
Return on Equity (ROE) -0.13

Liquidity (mrq)
Quick Ratio 24.49
Current Ratio 22.06

Balance Sheet (mrq) ($M)
Current Assets 164.09
Assets 226.30
Liabilities 7.33
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -41.22
Net Income -35.59

Cash Flow Statement (mra) ($M)
Cash From Operations -33.34
Cash from Investing -54.10
Cash from Financing -0.20

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-16 13G Lynx1 Capital Management LP 5.80
02-14 13G Rtw Investments, Lp 6.40
02-14 13G/A Biotechnology Value Fund L P 19.99 12.13
02-14 13G/A Venrock Healthcare Capital Partners II, L.P. 2.50 -62.52
02-14 13G/A Ra Capital Management, L.p. 10.70 0.47
02-09 13G/A Fmr Llc 6.03 -29.60

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 90,096 132,797 67.84
2024-05-02 38,544 8,454 455.93
2024-05-01 3,076 74,202 4.15
2024-04-30 22,663 8,419 269.19
2024-04-29 2,738 2,508 109.17

(click for more detail)

Similar Companies
FOLD – Amicus Therapeutics, Inc. FULC – Fulcrum Therapeutics, Inc.
GANX – Gain Therapeutics, Inc. GLYC – GlycoMimetics, Inc.
GRTX – Galera Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io